Oral solid dose (OSD) manufacturing is entering a new era, driven by rising demand for complex formulations, faster timelines and therapies designed around patient needs. As the industry evolves, manufacturers must navigate increasing technical complexity while maintaining quality, reliability and regulatory compliance.

Our eBook explores the key trends shaping the future of OSD manufacturing — from the shift toward Pharma 5.0 and digital innovation to the growing focus on patient‑centric dosage forms, challenging APIs and flexible manufacturing and packaging strategies. Discover how advanced technologies, data‑driven insights and deep scientific expertise are helping transform OSD production to be smarter, faster and more resilient.

Powered by Pfizer’s global network and decades of experience, Pfizer CentreOne brings the capabilities, scale and insight needed to help simplify complexity, accelerate development and deliver high‑quality OSD therapies to patients worldwide.